Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
BEAT
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios
Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio, the higher the stock value. The reasoning behind this is s…
HeartBeam (NASDAQ:BEAT) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit ht…
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to report quarterly earnings at $0.01 per share on revenue of $72.97 million. • Dominari Holdings (NASDAQ:DOMH) is projected to report earnings for its first quarter…
HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold Forever
HeartBeam Inc. (NASDAQ:BEAT) is one of the best NASDAQ growth stocks to buy and hold forever. On April 14, HeartBeam announced the pricing of a $10 million underwritten public offering, consisting of 12,500,000 shares of common stock. The…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Elong Power Holding Ltd. 286,995,635 0.0734 0.0576 0.0587 +0.0107 BioResto…
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize cardiac diagnostics. The approval came af…
FDA Clears First-Ever, Cable-Free Synthesized 12-Lead ECG For At-Home Arrhythmia Care; BEAT Surges
(RTTNews) - HeartBeam, Inc. (BEAT) announced that the U.S. FDA has granted 510(k) clearance for its proprietary cable-free synthesized 12-lead Electrocardiogram (ECG) system, making it the first FDA-cleared device designed to deliver full…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Pasithea Therapeutics Corp. 98,872,266 2.06 1.34 1.3799 +0.3199 HeartBeam…
HeartBeam Outlines Regulatory Path Following FDA NSE Decision On 12-Lead ECG Synthesis Software
(RTTNews) - HeartBeam Inc. (BEAT), on Wednesday, announced its regulatory strategy after receiving a Not Substantially Equivalent (NSE) decision from the U.S. Food and Drug Administration (FDA) on its 510(k) submission for the company's 12…
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan C…
HeartBeam (NASDAQ:BEAT) reported its Q2 2025 results on July 16, 2025, reaffirming key regulatory and commercial milestones and announcing a 23% sequential decrease in cash burn to $3.4 million. The company finished with a $5.1 million cas…
Image source: The Motley Fool. DATE Wednesday, August 13, 2025 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Rob Eno Chief Financial Officer — Tim Cruickshank Vice President, Investor Relations — Ian Scargill Need a quote fro…
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
HeartBeam Inc (NASDAQ:BEAT [https://www.chartmill.com/stock/quote/BEAT]) reported its second-quarter 2025 financial results, posting a net loss of $5.0 million, or $(0.15) per share, compared to a net loss of $5.0 million, or $(0.19) per s…
HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology
FDA-cleared technology makes clinical-grade ECG insights for arrhythmia assessment available outside of a medical facility SANTA CLARA, Calif., July 22, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company fo…
HeartBeam elects directors and approves equity plan amendment at annual meeting
HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company currently valued at $42.26 million, held its annual meeting of stockholders on Friday, July 11, 2025, conducted virtually via live webcast, according to a statement based on a rec…
MDB Capital Holdings Provides First Quarter 2025 Update
Addison, TX, May 21, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, today provides an update on operations throug…
Altamira Therapeutics (NASDAQ:CYTO) stock is rocketing higher on Friday following the release of positive results from a nasal spray test. woman in a white shirt wearing a face mask while at an airport representing CYTO Stock. Source: Mari…
SNDL, TLRY, ACB, CGC: Why Are Marijuana Stocks Up Today?
Investors are wondering why are marijuana stocks up today and we’ve got the answers to that question! Image of marijuana leaves growing on a plant representing the question Why Are Marijuana Stocks Up Today? Source: Yarygin / Shutterstock.…
SNDL Stock: The Good News That Has Cannabis Play Sundial Growers Heading Higher Today
Sundial Growers (NASDAQ:SNDL) stock is on the rise Friday following a couple of bits of positive news from the marijuana company. multiple jars of different sizes carrying marijuana representing SNDL stock. Source: Shutterstock Starting of…
In this article, we will be looking at the 10 best dividend stocks to buy under $20. To skip our detailed analysis of dividend investing, you can click to see the 5 Best Dividend Stocks to Buy Under $20. Dividend investing has existed in t…
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we hav…
Philips Divests Appliances Business To Hillhouse For $4.4B: Bloomberg
Royal Philips NV (NYSE: PHG) is divesting its domestic-appliances unit to private equity firm Hillhouse Capital in a deal worth $4.4 billion (€3.7 billion) to accelerate its conversion into a healthcare equipment maker post exit from the c…
Philips completes the acquisition of BioTelemetry, Inc.
February 9, 2021 Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in he…
Philips successfully completes tender offer for BioTelemetry, Inc.
February 9, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has successfully completed its previously announced tender offer (the “Offer”) to purchase al…
Investors Bancorp Set to Join S&P SmallCap 600
NEW YORK, Feb. 2, 2021 /PRNewswire/ -- Investors Bancorp Inc. (NASD: ISBC) will replace BioTelemetry Inc. (NASD: BEAT) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 10. Koninklijke Philips N.V. (N…
Investors Bancorp Set to Join S&P SmallCap 600
NEW YORK, Feb. 2, 2021 /PRNewswire/ -- Investors Bancorp Inc. (NASD: ISBC) will replace BioTelemetry Inc. (NASD: BEAT) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 10. Koninklijke Philips N.V. (N…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALXN, MGLN, FLIR, BEAT; Shareholders Are Encouraged to Contact the Firm
NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) concerning potential violations of the fed…
Moore Kuehn Encourages TNAV, ATAC, BEAT, and FTIV Investors to Contact Law Firm
NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merge…
Moore Kuehn Encourages TNAV, ATAC, BEAT, and FTIV Investors to Contact Law Firm
NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merge…
Moore Kuehn Encourages TNAV, ATAC, BEAT, and FTIV Investors to Contact Law Firm
NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merge…
Why It Might Be Time To Pay Attention To These 3 Red-Hot Health Stocks
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Lifshitz Law Firm, P.C. Announces Investigation of BEAT, HBAN, and CKH
NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: BioTelemetry, Inc. (NASDAQ:BEAT) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BEAT to Royal P…
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies – BEAT, HBAN, PS, CKH
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: BioTelemetry, Inc. (NASDAQ: BEAT) concerning potential violations of the federal securi…
Moore Kuehn Encourages BEAT, AJRD, ANCN, and RNET Investors to Contact Law Firm
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merge…
(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?
SAN DIEGO, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT) breached their fiduciary duties in connection wi…